Array BioPharma to Present at the Lazard Annual Healthcare and Jefferies 2012 Global Healthcare Conferences
BOULDER, Colo., Nov. 7, 2012 /PRNewswire/ — Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.
Event: Lazard Capital Markets 9th Annual Healthcare Conference Date: Tuesday, November 13, 2012 Time: 11:00 a.m. Eastern Time Location: The Pierre Hotel, New York, NY Event: Jefferies 2012 Global Healthcare Conference Date: Thursday, November 15, 2012 Time: 2:20 p.m. Greenwich Mean Time Location: London, England
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small?molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly?owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013. For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Tricia Haugeto
Array BioPharma Inc.
SOURCE Array BioPharma Inc.